T:

Kyung-Nam Koh1, Dae Hee Kim2, Hyori Kim3

  • 1Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Seminars in hematology
|December 18, 2025
PubMed
概括

三特异性抗体是一种新的免疫疗法,增强T细胞参与,以克服双特异性抗体在血液癌症中的局限性. 早期试验显示了高响应率,正在进行的研究正在应对挑战.